Previous 10 | Next 10 |
home / stock / ipci:cc / ipci:cc news
TORONTO, ON / ACCESSWIRE / July 14, 2023 / Intellipharmaceutics International Inc. (OTCQB:IPCIF and TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-release...
Canadian Investment Regulatory Organization Trade Resumption - IPCI Canada NewsWire TORONTO , June 8, 2023 /CNW/ - Trading resumes in: Company: IntelliPharmaCeutics International Inc. TSX Symbol: IPCI All Issues: Yes Resumption (ET): 1...
Intellipharmaceutics Announces Fiscal Year 2022 and First Quarter 2023 Results Canada NewsWire TORONTO , June 6, 2023 /CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical c...
Intellipharmaceutics Announces Cease Trade Order Canada NewsWire TORONTO , March 7, 2023 /CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the...
IIROC Trading Halt - IPCI Canada NewsWire TORONTO , March 7, 2023 /CNW/ - The following issues have been halted by IIROC: Company: IntelliPharmaCeutics International Inc. TSX Symbol: IPCI All Issues: Yes Reason: Cease Trade Order Halt ...
Intellipharmaceutics Provides Update on Management Cease Trade Order Application and Anticipates Cease Trade Order Canada NewsWire TORONTO , Feb. 7, 2023 /CNW/ - Intellipharmaceutics International Inc. (OTCQB: IPCIF) (TSX: IPCI) (" Intellipharmaceutics " or t...
Intellipharmaceutics Announces its Expected Delay in Filing Annual Audited Financial Statements and Annual Information Form and its Management Cease Trade Order Application Canada NewsWire TORONTO , Feb. 6, 2023 /CNW/ - Intellipharmaceutics International Inc. (OT...
TORONTO, ON / ACCESSWIRE / October 14, 2022 / - Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-r...
TORONTO, ON / ACCESSWIRE / August 16, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-rele...
TORONTO, ON / ACCESSWIRE / July 21, 2022 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) ("Intellipharmaceutics" or the "Company"), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-releas...
News, Short Squeeze, Breakout and More Instantly...
Intellipharmaceutics International Inc. Company Name:
IPCI:CC Stock Symbol:
TSXC Market:
TORONTO, ON / ACCESSWIRE / June 14, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF) and (TSX:IPCI.H) (" Intellipharmaceutics " or the " Company "), announced today that its common stock, currently traded on the OTCQB market, is expected to be downgraded to the OTC Expert Market on J...
TORONTO, ON / ACCESSWIRE / March 13, 2024 / Intellipharmaceutics International Inc. (OTCQB:IPCIF)(TSX:IPCI) - (" Intellipharmaceutics " or the " Company "), a pharmaceutical company specializing in the research, development and manufacture of novel and generic controlled-release and targeted-rel...
Canadian Investment Regulatory Organization Trading Halt - IPCI Canada NewsWire TORONTO , March 6, 2024 /CNW/ - The following issues have been halted by CIRO: Company: IntelliPharmaCeutics International Inc. TSX Symbol: IPCI All Issues: Yes Reason: Ce...